메뉴 건너뛰기




Volumn 12, Issue 2, 2006, Pages 213-218

Monitoring of plasmin and plasminogen activator activity in blood of patients under fibrinolytic treatment by reteplase

Author keywords

Laboratory medicine; Plasmin; Plasminogen activator; Thrombolysis

Indexed keywords

ARGININE; EDETIC ACID; OXYGEN; PLASMIN; PLASMINOGEN ACTIVATOR; RETEPLASE; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN;

EID: 33747754445     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960601200210     Document Type: Article
Times cited : (9)

References (28)
  • 1
    • 0030983708 scopus 로고    scopus 로고
    • Mortality by cause for eight regions of the world: Global burden of disease study
    • Murray CL, Lopez AD. Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 1997;349:1269.
    • (1997) Lancet , vol.349 , pp. 1269
    • Murray, C.L.1    Lopez, A.D.2
  • 3
    • 0028646227 scopus 로고
    • Physiology of thrombosis
    • Bick RL, Murano G. Physiology of thrombosis. Clin Lab Med 1994;14:677.
    • (1994) Clin Lab Med , vol.14 , pp. 677
    • Bick, R.L.1    Murano, G.2
  • 4
    • 0033964879 scopus 로고    scopus 로고
    • A simple functional screening assay for fibrinolysis parameters (FIPA)
    • Stief TW, Hinz F, Kurz J, et al. A simple functional screening assay for fibrinolysis parameters (FIPA). Thromb Res 2000;97:231.
    • (2000) Thromb Res , vol.97 , pp. 231
    • Stief, T.W.1    Hinz, F.2    Kurz, J.3
  • 5
    • 0012133835 scopus 로고    scopus 로고
    • Tenecteplase: A review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction
    • Dunn CJ, Goa KL. Tenecteplase: A review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction. Am J Cardiovasc Drugs 2001;1:51.
    • (2001) Am J Cardiovasc Drugs , vol.1 , pp. 51
    • Dunn, C.J.1    Goa, K.L.2
  • 6
    • 0142209155 scopus 로고    scopus 로고
    • Thrombolysis: Newer thrombolytic agents and their roles in clinical medicine
    • Nordt TK, Bode C. Thrombolysis: Newer thrombolytic agents and their roles in clinical medicine. Heart 2003;89:1358.
    • (2003) Heart , vol.89 , pp. 1358
    • Nordt, T.K.1    Bode, C.2
  • 7
    • 1642273924 scopus 로고    scopus 로고
    • Clinical perspectives and therapeutics of thrombolysis
    • Khan IA, Gowda RM. Clinical perspectives and therapeutics of thrombolysis. Int J Cardiol 2003;91:115.
    • (2003) Int J Cardiol , vol.91 , pp. 115
    • Khan, I.A.1    Gowda, R.M.2
  • 8
    • 0037319316 scopus 로고    scopus 로고
    • Thrombolytic therapy: Clinical applications
    • Baker WF Jr. Thrombolytic therapy: Clinical applications. Hematol Oncol Clin North Am 2003;17:283.
    • (2003) Hematol Oncol Clin North Am , vol.17 , pp. 283
    • Baker Jr., W.F.1
  • 9
    • 0036987383 scopus 로고    scopus 로고
    • Present-day thrombolytic therapy: Therapeutic agents - Pharmacokinetics and pharmacodynamics
    • Bell WR. Present-day thrombolytic therapy: Therapeutic agents - pharmacokinetics and pharmacodynamics. Rev Cardiovasc Med 2002;3(suppl 2):S34.
    • (2002) Rev Cardiovasc Med , vol.3 , Issue.2 SUPPL.
    • Bell, W.R.1
  • 10
    • 0742323181 scopus 로고    scopus 로고
    • The evolution of thrombolytic therapy and adjunctive antithrombotic regimens in acute ST-segment elevation myocardial infarction
    • Chen M, Arjomand H, Pollack CV Jr. The evolution of thrombolytic therapy and adjunctive antithrombotic regimens in acute ST-segment elevation myocardial infarction. Am J Emerg Med 2004;22:14.
    • (2004) Am J Emerg Med , vol.22 , pp. 14
    • Chen, M.1    Arjomand, H.2    Pollack Jr., C.V.3
  • 11
    • 0141721613 scopus 로고    scopus 로고
    • Stroke: Killer clots and killer drugs
    • Warlow C. Stroke: Killer clots and killer drugs. J Thromb Haemost 2003;1:1422.
    • (2003) J Thromb Haemost , vol.1 , pp. 1422
    • Warlow, C.1
  • 12
    • 22544442454 scopus 로고    scopus 로고
    • Functional determination of plasmin in arginine-stabilized plasma
    • Stief TW, Richter A, Bünder R, et al. Functional determination of plasmin in arginine-stabilized plasma. Clin Appl Thromb Hemost 2005;11:303.
    • (2005) Clin Appl Thromb Hemost , vol.11 , pp. 303
    • Stief, T.W.1    Richter, A.2    Bünder, R.3
  • 13
    • 22544485964 scopus 로고    scopus 로고
    • Functional determination of plasminogen-activator in arginine-stabilized plasma
    • Stief TW, Richter A, Bünder R, et al. Functional determination of plasminogen-activator in arginine-stabilized plasma. Clin Appl Thromb Hemost 2005;11:311.
    • (2005) Clin Appl Thromb Hemost , vol.11 , pp. 311
    • Stief, T.W.1    Richter, A.2    Bünder, R.3
  • 14
    • 0022204974 scopus 로고
    • Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue type plasminogen activator (rt-PA) in humans
    • Verstraete M, Bounameaux H, de Cock F, et al. Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue type plasminogen activator (rt-PA) in humans. J Pharmacol Exp Ther 1985;235:506.
    • (1985) J Pharmacol Exp Ther , vol.235 , pp. 506
    • Verstraete, M.1    Bounameaux, H.2    De Cock, F.3
  • 15
    • 0021215285 scopus 로고
    • Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethyl ketones
    • Lijnen HR, Uytterhoeven M, Collen D. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethyl ketones. Thromb Res 1984;34:431.
    • (1984) Thromb Res , vol.34 , pp. 431
    • Lijnen, H.R.1    Uytterhoeven, M.2    Collen, D.3
  • 16
    • 0022977920 scopus 로고
    • D-Phe-Pro-Arg-chloromethylketone: Its potential use in inhibiting the formation of in vitro artefacts in blood collected during tissue-type plasminogen activator thrombolytic therapy
    • Mohler MA, Refino CJ, Chen SA, et al. D-Phe-Pro-Arg-chloromethylketone: Its potential use in inhibiting the formation of in vitro artefacts in blood collected during tissue-type plasminogen activator thrombolytic therapy. Thromb Haemost 1986;56:160.
    • (1986) Thromb Haemost , vol.56 , pp. 160
    • Mohler, M.A.1    Refino, C.J.2    Chen, S.A.3
  • 17
    • 0023611518 scopus 로고
    • 2Cl and aprotinin for prevention of in vitro effects of recombinant tissue-type plasminogen activator on haemostasis parameters
    • 2Cl and aprotinin for prevention of in vitro effects of recombinant tissue-type plasminogen activator on haemostasis parameters. Thromb Haemost 1987;58:921.
    • (1987) Thromb Haemost , vol.58 , pp. 921
    • Seifried, E.1    Tanswell, P.2
  • 19
    • 0027057301 scopus 로고
    • Bolus application of a novel recombinant plasminogen activator in acute myocardial infarction patients: Pharmacokinetics and effects on the hemostatic system
    • Seifried E, Müller M, Martin U, et al. Bolus application of a novel recombinant plasminogen activator in acute myocardial infarction patients: Pharmacokinetics and effects on the hemostatic system. Ann NY Acad Sci 1992;667:417.
    • (1992) Ann NY Acad Sci , vol.667 , pp. 417
    • Seifried, E.1    Müller, M.2    Martin, U.3
  • 20
    • 0026329223 scopus 로고
    • Nonradical oxidants of the phagocyte type induce the activation of plasmatic single-chain urokinase
    • Stief TW, Stief MH, Ehrenthal W, et al. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single-chain urokinase. Thromb Res 1991;64:597.
    • (1991) Thromb Res , vol.64 , pp. 597
    • Stief, T.W.1    Stief, M.H.2    Ehrenthal, W.3
  • 21
    • 0042329730 scopus 로고    scopus 로고
    • In vitro simulation of therapeutic plasmatic thrombolysis
    • Stief TW, Bünder R, Richter A, et al. In vitro simulation of therapeutic plasmatic thrombolysis. Clin Appl Thromb Hemost 2003;9:211.
    • (2003) Clin Appl Thromb Hemost , vol.9 , pp. 211
    • Stief, T.W.1    Bünder, R.2    Richter, A.3
  • 22
    • 0017598164 scopus 로고
    • Increased blood fibrinolytic activity after aspirin ingestion
    • Moroz LA. Increased blood fibrinolytic activity after aspirin ingestion. N Engl J Med 1977;296:525.
    • (1977) N Engl J Med , vol.296 , pp. 525
    • Moroz, L.A.1
  • 24
    • 0033934574 scopus 로고    scopus 로고
    • The blood fibrinolysis/deep-sea analogy: A hypothesis on the cell signals singlet oxygen/photons as natural antithrombotics
    • Stief TW. The blood fibrinolysis/deep-sea analogy: A hypothesis on the cell signals singlet oxygen/photons as natural antithrombotics. Thromb Res 2000;99:1.
    • (2000) Thromb Res , vol.99 , pp. 1
    • Stief, T.W.1
  • 25
    • 0034235394 scopus 로고    scopus 로고
    • The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment
    • Sigal A, Bleijs DA, Grabovsky V, et al. The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment. J Immunol 2000;165:442.
    • (2000) J Immunol , vol.165 , pp. 442
    • Sigal, A.1    Bleijs, D.A.2    Grabovsky, V.3
  • 26
    • 0025289588 scopus 로고
    • Neutrophil adherence to isolated adult canine myocytes. Evidence for a CD18-dependent mechanism
    • Entman ML, Youker K, Shappell SB, et al. Neutrophil adherence to isolated adult canine myocytes. Evidence for a CD18-dependent mechanism. J Clin Invest 1990;85:1497.
    • (1990) J Clin Invest , vol.85 , pp. 1497
    • Entman, M.L.1    Youker, K.2    Shappell, S.B.3
  • 27
    • 0025219115 scopus 로고
    • Adherence-dependent neutrophil hydrogen peroxide secrection is mediated by Mac-1 (CD11/18)
    • Shapell SB, Toman C, Anderson DC, et al. Adherence-dependent neutrophil hydrogen peroxide secrection is mediated by Mac-1 (CD11/18). J Immunol 1989;144:2702.
    • (1989) J Immunol , vol.144 , pp. 2702
    • Shapell, S.B.1    Toman, C.2    Anderson, D.C.3
  • 28
    • 0029962461 scopus 로고    scopus 로고
    • Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene
    • Grether-Beck S, Olaizola-Horn S, Schmitt H, et al. Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci USA 1996;93:14586.
    • (1996) Proc Natl Acad Sci USA , vol.93 , pp. 14586
    • Grether-Beck, S.1    Olaizola-Horn, S.2    Schmitt, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.